HIGHLIGHTS
- who: Benjamin J. Borgert et al. from the State University College of Medicine, Tallahassee FL, United States have published the article: The availability of gonadotropin therapy from FDA-approved pharmacies for men with hypogonadism and infertility, in the Journal: (JOURNAL) of August/22,/2022
- what: The authors sought to investigate ways to decrease disparities in the treatment of male hypogonadism by increasing access to gonadotropin therapy by identifying 503b outsourcing pharmacies which currently provide gonadotropin therapy. Limitations of this article were the following: no non-FDA-approved compounding pharmacies such as 503a pharmacies were contacted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.